Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
11.70
+0.52 (4.65%)
At close: Mar 16, 2026, 4:00 PM EDT
11.58
-0.12 (-1.03%)
After-hours: Mar 16, 2026, 4:10 PM EDT
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $322.41 million as of March 16, 2026.
Market Cap
322.41M
Enterprise Value
107.56M
1-Year Change
n/a
Ranking
Category
Stock Price
$11.70
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has increased from $308.79M to $322.41M, an increase of 4.41%. That is a compound annual growth rate of 6.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 371.33M | 60.15% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuneering | 326.50M |
| NovaBridge Biosciences | 326.27M |
| Silence Therapeutics | 325.91M |
| X4 Pharmaceuticals | 322.64M |
| XOMA Royalty | 313.62M |
| Context Therapeutics | 308.71M |
| AC Immune | 306.85M |
| Polaryx Therapeutics | 301.10M |